Evidence map›Paper›PMID 40678601›Full record

ArticlePlastic and reconstructive surgery. Global open2025

Disparities in Facial Feminization Surgery Coverage: MassHealth Versus Private Insurance Coverage in Massachusetts.

Jessica J Farzan, Quynh Anh Annie Phan, Janelle P Renterghem, Wen Ting Zheng, Anna Bogursky, Janice F Lalikos, Joyce K McIntyre

Abstract read
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jessica J FarzanFrom the UMass Chan Division of Plastic Surgery, Worcester, MA.
Quynh Anh Annie PhanFrom the UMass Chan Division of Plastic Surgery, Worcester, MA.
Janelle P RenterghemFrom the UMass Chan Division of Plastic Surgery, Worcester, MA.
Wen Ting ZhengFrom the UMass Chan Division of Plastic Surgery, Worcester, MA.
Anna BogurskyFrom the UMass Chan Division of Plastic Surgery, Worcester, MA.
Janice F LalikosFrom the UMass Chan Division of Plastic Surgery, Worcester, MA.
Joyce K McIntyreFrom the UMass Chan Division of Plastic Surgery, Worcester, MA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Facial feminization surgery (FFS) is a component of gender-affirming care for transgender women and includes a variety of surgical procedures with the unified goal of improving patients' quality of life and mitigating mental distress. This study examined insurance coverage, costs, and claim denials for commonly desired FFS procedures in Massachusetts. Methods: Data from the Massachusetts Center for Health Information and Analysis claims database (2016-2021) were analyzed for transgender patients undergoing FFS procedures in Massachusetts. The study focused on comparing costs and denial rates between public and private insurance for frontal bone reduction, eyebrow lift, upper and lower blepharoplasty, canthopexy, rhinoplasty, genioplasty, and tracheal shave. Results: A total of 656 FFS claims were analyzed, with tracheal shave as the most frequently claimed procedure (n = 176), followed by rhinoplasty (n = 165). Private insurance patients incurred 2-4 times higher out-of-pocket costs than public patients, who generally had no copayments. Additionally, private insurance exhibited significantly higher claim denial rates compared with public insurance. Conclusions: Our findings revealed significant differences in insurance coverage, reimbursement, and claim denials for procedures across different insurance types in Massachusetts. These differences arise from varying interpretations of medical necessity, the dual cosmetic and functional nature of certain procedures, and the deeply personal experience of gender dysphoria. Our findings emphasize the need for expanded outcomes research on the efficacy and potential complications of FFS to better inform and enhance the comprehensive care provided to transgender patients.

Identifiers

PMID40678601
PMCPMC12269817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.